Inventor · disambiguated record
Margaret Lee
Also filed as: LEE MARGARET · LEE MARGARET S · LEE MARGARET SCOTT
7 granted patents·19 pending applications·21 citations·filing 2003–2025
80Inventor score
Top patents by PatentIndex Score
26 records- 0191US11427540B2Formulations of T-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2021·Granted Aug 30, 2022·4 cites·9 claims
- 0289US12077502B2Formulations of T-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2022·Granted Sep 3, 2024·2 cites·35 claims
- 0388US11311522B1Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamideCAVION INC·Filed 2021·Granted Apr 26, 2022·3 cites·25 claims
- 0483US7795310B2Methods and reagents for the treatment of metabolic disordersCOMBINATORX INC·Filed 2005·Granted Sep 14, 2010·12 cites·6 claims
- 0580US2024417375A1Formulations of t-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 0667US12383539B2Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)ethyl)acetamideCAVION INC·Filed 2019·Granted Aug 12, 2025·0 cites·32 claims
- 0766US2025312323A1Treating essential tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamideCAVION INC·Filed 2025·Application pending·0 cites
- 0863US11236078B2Heterocyclic inhibitors of the sodium channelDEGIACOMO MARK G·Filed 2019·Granted Feb 1, 2022·0 cites·2 claims
- 0960US2007099905A1Combinations of drugs for the treatment of neoplasmsBORISY ALEXIS·Filed 2006·Application pending·0 cites
- 1058US2005100508A1Methods for identifying drug combinations for the treatment of proliferative diseasesFiled 2004·Application pending·0 cites
- 1157US2010009934A1Beta adrenergic receptor agonists for the treatment of b-cell proliferative disordersCOMBINATORX INC·Filed 2009·Application pending·0 cites
- 1255US2024238261A1Method of treating essential tremorCAVION INC·Filed 2022·Application pending·0 cites
- 1354US2004116407A1Combinations of drugs for the treatment of neoplasmsFiled 2003·Application pending·0 cites
- 1453US2005158320A1Combinations for the treatment of proliferative diseasesFiled 2004·Application pending·0 cites
- 1552US2009053168A1Treatments of b-cell proliferative disordersRICKLES RICHARD·Filed 2008·Application pending·0 cites
- 1652US2009047243A1Combinations for the treatment of b-cell proliferative disordersRICKLES RICHARD·Filed 2008·Application pending·0 cites
- 1751US2007179152A1Combination therapy for the treatment of neoplasmsLEE MARGARET S·Filed 2004·Application pending·0 cites
- 1851US2006241122A1Combination therapy for the treatment of neoplasmsLEE MARGARET S·Filed 2004·Application pending·0 cites
- 1949US2006177864A1Methods for identifying drug combinations for the treatment of proliferative diseasesNICHOLS M J·Filed 2006·Application pending·0 cites
- 2048US2017145003A1Heterocyclic inhibitors of the sodium channelDEGIACOMO MARK G·Filed 2015·Application pending·0 cites
- 2146US2005054708A1Combinations of drugs for the treatment of neoplasmsFiled 2004·Application pending·0 cites
- 2245US2004253642A1System and method for multidimensional evaluation of combinations of compositionsFiled 2004·Application pending·0 cites
- 2345US2006264384A1Compositions and methods for treatment for neoplasmsJOHANSEN LISA M·Filed 2006·Application pending·0 cites
- 2445US2004253627A1System and method for multidimensional evaluation of combinations of compositionsFiled 2004·Application pending·0 cites
- 2540US2005137185A1Combinations of drugs for the treatment of neoplasmsFiled 2004·Application pending·0 cites
- 2639US11602530B2CRM1 inhibitors for treating epilepsyBIOGEN MA INC·Filed 2017·Granted Mar 14, 2023·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Margaret Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →